Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12962773 | 0.85 | SIGMAR1 (0.44) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL12962543 | 0.85 | SIGMAR1 (0.44) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL3109210 | 0.85 | SIGMAR1 (0.44) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL8406252 | 0.84 | SIGMAR1 (0.48) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL8406247 | 0.82 | SIGMAR1 (0.43) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL28244756 | 0.81 | SIGMAR1 (0.42) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL8406257 | 0.81 | SIGMAR1 (0.42) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL3101532 | 0.80 | SIGMAR1 (0.43) | SIGMAR1CHRM2CHRM1 | |
| SCHEMBL6908034 | 0.80 | — | — | |
| SCHEMBL9559688 | 0.79 | SIGMAR1 (0.43) | SIGMAR1CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2640507-B1 | ACID GAS ABSORBENT COMPOSITION | NALCO CO (US) | 2019-05-08 | — | — | EP | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2924053-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID COMPOUND OR SALT THEREOF | Glytech, Inc. (JP) | 2015-09-30 | — | — | EP | disclosed |
| US-8765951-B2 | Acid gas absorbent composition | NALCO COMPANY (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765083-B2 | Acid gas absorbent composition | NALCO COMPANY (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765951-B2 | Acid gas absorbent composition | NALCO COMPANY (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765083-B2 | Acid gas absorbent composition | NALCO COMPANY (US) | 2014-07-01 | — | — | US | disclosed |
| US-20130240782-A1 | ACID GAS ABSORBENT COMPOSITION | CHAMPIONX LLC | 2013-09-19 | — | — | US | disclosed |
| US-20130240782-A1 | ACID GAS ABSORBENT COMPOSITION | CHAMPIONX LLC | 2013-09-19 | — | — | US | disclosed |
| US-20120128561-A1 | ACID GAS ABSORBENT COMPOSITION | US SYNTHETIC CORPORATION | 2012-05-24 | — | — | US | disclosed |
| US-20120128561-A1 | ACID GAS ABSORBENT COMPOSITION | US SYNTHETIC CORPORATION | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | CD44, CSGALNACT1, UGGT1 | SIGMAR1 1424/4885CHRM2 4385/4885CHRM1 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.